Benzene

Environmental Toxicants: Human Exposures and Their Health Effects: Third Edition

Volumn , Issue , 2008, Pages 459-498

  Goldstein, Bernard D ^a   Witz, Gisela ^b  

^a UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^b RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

Benzene exposure metabolism and disposition; Leukemia associated with low level benzene exposure; Toxic metabolites responsible for benzene toxicity and mechanisms of toxic metabolite action

Indexed keywords

EID: 84889834481     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470442890.ch13     Document Type: Chapter

References (232)

1. Aksoy M (1985) Benzene as a leukemogenic and carcinogenic agent. Am. J. Ind. Med. 8:9-20.
2. Aksoy M, Dincol K, Akgun T, Erdem S, Dincol G (1971) Haematological effects of chronic benzene poisoning in 217 workers. Br. J. Ind. Med. 28:296-302.
3. Aksoy M, Erdem S, Dincol G, Kutlar A, Bakioglu I, Hepyuksel T (1984) Clinical observations showing the role of some factors in the etiology of multiple myeloma. Acta Haematol. 71:116-120.
4. Albertini R, Clewell H, Himmelstein MW, Morinello E, Olin S, Preston J, Scarano L, Smith MT, Swenberg J, Tice R, Travis C (2003) The use of non-tumor data in cancer risk assessment: reflections on butadiene, vinyl chloride, and benzene. Regul. Toxicol. Pharmacol. 37:105-132.
5. Ali R,Yu CL,WuMT,Ho CK, Pan BJ, Smith T, Christiani DC (2004)A case-control study of parental occupation, leukemia and brain tumors in an industrial city in Taiwan. J. Occup. Environ. Med. 46:985-992.
6. Amin R,WitzG(2001)DNA-protein crosslink andDNAstrand break formation in HL-60 cells treated with trans,trans-muconaldehyde, hydroquinone and their mixtures. Int. J. Toxicol. 20:69-80.
7. Andrews LS, Lee EW, Witmer CM, Kocsis JJ, Snyder R (1977) Effects of toluene on the metabolism, disposition, and hemopoietic toxicity of 3H-benzene. Biochem. Pharmacol. 26:293-300.
8. Andrews LS, Lee EW,Witmer CM, Kocsis JJ (1979) 3H-benzene metabolism in rabbit bone marrow. Life Sci. 25:567-572.
9. Ashley DL, BoninMA,Cardinali FL, McCraw JM,Wooten JV (1994) Blood concentrations of volatile organic compounds in a nonoccupationally exposed US population and in groups with suspected exposure. Clin. Chem. 40:1401-1404.
10. Baarson KA, Snyder CA, Green JD, Sellakumar A, Goldstein BD, Albert RE (1982) The hematotoxic effects of inhaled benzene on peripheral blood, bone marrow, and spleen cells are increased by ingested ethanol. Toxicol. Appl. Pharmacol. 64:393-404.
11. Bagby GC (1987) Production of multilineage growth factors by hematopoietic stromal cells: an intercellular regulatory network involving mononuclear phagocytes and interleukin-1. Blood Cells 13:147-159.
12. Barale R, Marrazzini A, Betti C, Vangelisti V, Loprieno N, Barrai I (1990) Genotoxicity of two metabolites of benzene: phenol and hydroquinone show strong synergistic effects in vivo. Mutat. Res. 244:15-20.
13. Bauer AK, Faiola B, Abernethy DJ, Marchan M, Pluta LJ, Wong VA, Roberts K, Jaiswal AK, Gonzalez FJ, Butterworth BE, Borghoff S, Parkinson H, Everitt J, Recio L (2003) Genetic susceptibility to benzene-induced toxicity: role of NADPH:quinone oxidoreductase-1. Cancer Res. 63:929-935.
14. Bechtold WE, Henderson RF (1993) Biomarkers of human exposure to benzene. J. Toxicol. Environ. Health 40:377-386.
15. Bergsagel DE, Wong O, Bergsagel PL, Alexanian R, Anderson K, Kyle RA, Raabe GK (1999) Benzene and multiple myeloma: appraisal of the scientific evidence. Blood 94:1174-1182.
16. Bird MG, Greim H, Snyder R, Rice JM (2005) Recent advances in benzene toxicity. Chem. Biol. Interact. 153-154:1-5.
17. Bolcsak LE, Nerland DE (1983) Inhibition of erythropoiesis by benzene and benzene metabolites. Toxicol. Appl. Pharmacol. 69:363-368.
18. Boley S, Wong VA, French JE, Recio L (2002) p53 heterozygosity alters the mRNA expression of p53 target genes in the bone marrow in response to inhaled benzene. Toxicol. Sci. 66:209-215.
19. Bratton SB, Lau SS, Monks TJ (1997) Identification of quinol thioethers in bone marrow of hydroquinone/phenol-treated rats and mice and their potential role in benzene-mediated hematotoxicity. Chem. Res. Toxicol. 10:859-865.
20. Chang RL, Wang CQ, Kline SA, Conney AH, Goldstein BD, Witz G (1994) Mutagenicity of trans, trans-muconaldehyde and its metabolites in V79 cells. Environ. Mol. Mutagen. 24:112-115.
21. Chaney AM, Carlson GP (1995) Comparison of rat hepatic and pulmonary microsomal metabolism of benzene and the lack of benzene-induced pneumotoxicity and hepatotoxicity. Toxicology 104:53-62.
22. Chen H, Eastmond DA (1995a) Topoisomerase inhibition by phenolic metabolites: a potential mechanism for benzene's clastogenic effects. Carcinogenesis 16:2301-2307.
23. Chen H, EastmondDA(1995b) Synergistic increase in chromosomal breakage within the euchromatin induced by an interaction of the benzene metabolites phenol and hydroquinone in mice. Carcinogenesis 16:1963-1969.
24. Chen K-M, El-Bayoumy K, Cunningham J, Aliaga C, Li H, Melikian AA (2004) Detection of nitrated benzene metabolites in bone marrow of B6C3F1 mice treated with benzene. Chem. Res. Toxicol. 17:370-377.
25. Chen K-M, El-Bayoumy K, Hosey J, Cunningham J, Aliaga C, MelikianAA(2005) Benzene increases protein-bound 3-nitrotyrosine in bone marrow of B6C3F1 mice. Chem. Biol. Interact. 156:81-91.
26. Collins JJ, Ireland B, Buckley CF, Shepperly D (2003) Lymphohematopoietic cancer mortality among workers with benzene exposure. Occup. Environ. Med. 60:676-679.
27. Cosma GN, Jamasbi R, Marchok AC (1988) Growth inhibition and DNA damage induced by benzo[a]pyrene and formaldehyde in primary cultures of rat tracheal epithelial cells. Mutat. Res. 201:161-168.
28. Crump K, Allen B (1984) Quantitative Estimates of Risk of Leukemia from Occupational Exposure to Benzene. OSHA Docket H-059B. Washington, DC: OSHA.
29. Cuneo A, Bigoni R, Cavazzini F, Bardi A, Agostini P, Tammiso E, Ciccone N, Mancini M, Nanni M, De Cula R, Divona M, La Starza R, Crescenzi B,Testoni N, Rege Cambrin G, Mecuci C, Lo Coco F, Saglio G, Castoldi G (2002) Incidence and significance of cryptic chromosome aberrations detected by fluorescence in situ hybridization in acute myeloid leukemia with normal karyotype. Leukemia 16:1745-1751.
30. Dor F, LeMoullec Y, Festy B (1995) Exposure of city residents to carbon monoxide and monocyclic aromatic hydrocarbons during commuting trips in the Paris metropolitan area. J. Air Waste Manage. Assoc. 45: 2103-110.
31. Dosemeci M, Li G-L, Hayes RB, Yin S-N, Linet M, ChowW-H,Wang YZ, Jiang Z-L, Dai T-R, Zhang W-U, Chao X-J,Ye P-Z,Kou Q-R, FamY-H, Zhang X-C, Lin X-F, Meng J-F, Zho J-S,Wacholder S, Kneller R, Blot WJ (1994) Cohort study among workers exposed to benzene in China. II. Exposure assessment. Am. J. Ind. Med. 26:401-411.
32. Drummond JC, Finar IL (1938) Muconic acid as a metabolic product of benzene. Biochemistry 32:79-84.
33. Eastmond DA, Smith MT, Irons RD (1987) An interaction of benzene metabolites reproduces the myelotoxicity observed with benzene exposure. Toxicol. Appl. Pharmacol. 91:85-95.
34. Eastmond DA, Mondrala ST, Hasegawa L (2005) Topoisomerase II inhibition by myeloperoxidaseactivated hydroquinone: a potential mechanism underlying the genotoxic and carcinogenic effects of benzene. Chem. Biol. Interact. 153-154:207-216.
35. Forni AM, Cappellini A, Pacifico E, Vigliani EC (1971) Chromosome changes and their evolution in subjects with exposure to benzene. Arch. Environ. Health 23:385-391.
36. Forrest MS, Lan Q, Hubbard AE, Zhang L, Vermeulen R, Zhao X, Li G, Wu YY, Shen M, Yin S, Chanock SJ, Rothman N, Smith MT (2005) Discovery of novel biomarkers by microarray analysis of peripheral blood mononuclear cell gene expression in benzene-exposed workers. Environ. Health Perspect. 113:801-807.
37. Francis GE, Tejedor MC, Berney JJ, Chresta CM, Delgado C, Patel P (1994) Effects of DNA topoisomerase II inhibitors on human bone marrow progenitor cells. Leukemia 8(1):121-128.
38. Frantz CE, Chen H, Eastmond DA (1996) Inhibition of human topoisomerase II in vitro by bioactive benzene metabolites. Environ. Health Perspect. 104:1319-1323.
39. Franz TJ (1984) Percutaneous absorption of benzene. In: MacFarland HN, et al., editors. Advances in Modern Environmental Toxicology, Vol. VI. Applied Toxicology of Petroleum Hydrocarbons. Princeton, NJ: Princeton Scientific Publishers.
40. Gaskell M, McLuckie KIE, Farmer PB (2005) Genotoxicity of the benzene metabolites para-benzoquinone and hydroquinone. Chem. Biol. Interact. 153-154:267-270.
41. Genter MB, Recio L (1994) Absence of detectable P4502E1 in bone marrow of B6C3F1 mice: relevance to butadiene-induced bone marrow toxicity. Fundam. Appl. Toxicol. 22:469-473.
42. Glass DC, Gray CN, Jolley DJ, Gibbons C, Sim MR, Fritschi L, Adams GG, Bisby JA, Manuell RW (2003) Leukemia risk associated with low level benzene exposure. Epidemiology 14:569-577.
43. Glatt H, Padykdula R, Berchtold GA, Ludewig G, Platt KL, Klein J, Oesch F (1989) Multiple activation pathways of benzene leading to products with varying genotoxic characteristics. Environ. Health Perspect. 82:81-89.
44. Goldstein BD (1977) Hematotoxicity in humans. J. Toxicol. Environ. Health (Suppl.) 2:69-105.
45. Goldstein BD (1985) Risk assessment and risk management of benzene by the Environmental Protection Agency. In: Risk Quantitation and Regulatory Policy, Banbury Report, Vol. 19. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, pp. 293-304.
46. Goldstein BD (1988) Benzene toxicity. In: Weaver NK, editor. Occupational Medicine State of the Art Review: The Petroleum Industry. Philadelphia, PA: Hanley and Beltus, Inc., pp. 541-554.
47. Goldstein BD (1989a) Clinical hematotoxicity of benzene. In: BT Advances in Modern Environmental Toxicology, Vol. XVI. Benzene: Occupational and Environmental Hazards-Scientific Update. Princeton, NJ: Princeton Scientific Publishing, pp. 55-65.
48. Goldstein BD (1989b) Occam's razor is dull. Environ. Health Perspect. 82:3-6.
49. Goldstein BD (1990) Is exposure to benzene a cause of human multiple myeloma? Ann. N.Y. Acad. Sci. 609:225-334.
50. Goldstein BD (1994) Letter to the editor: response to the Valdez Air Study Review Committee. Risk Anal. 14:891-893.
51. Goldstein BD (2004) Letter to the editor re: Glass et al. Leukemia risk associated with low-level benzene exposure. Epidemiology 15:509-510.
52. Goldstein BD, KipenH(1991) Lessons on the second cancers resulting from cancer chemotherapy. In: Witmer CM, editor. Biological Reactive Intermediates, Vol. IV. New York: Plenum Press.
53. Goldstein BD, Shalit SL (2000) The causal relation between benzene exposure and multiple myeloma (Letter). Blood 95:4.
54. Goon D, Cheng X, Ruth J, Petersen DR, Ross D (1992) Metabolism of trans,trans-muconaldehyde by aldehyde and alcohol dehydrogenase: identification of a novel metabolite. Toxicol. Appl. Pharmacol. 114:147-155.
55. Gorsky LD, Coon MJ (1985) Evaluation of the role of free hydroxyl radicals in the cytochrome P-450 catalyzed oxidation of benzene and cyclohexanol. Drug Metab. Dispos. 13:169-174.
56. Greenlee WF, Gross EA, Irons RD (1981) Relationship between benzene toxicity and the disposition of 14C-labeled benzene metabolites in rat. Chem. Biol. Interact. 33:285-299.
57. Grotz VL, Ji S, Goldstein BD,Witz G (1994) Metabolism of benzene and trans,trans-muconaldehyde in the isolated perfused liver to trans,trans-muconic acid. Toxicol. Lett. 70:281-290.
58. Guenel P, Imbernon E, Chevalier A, Crinquand-Calastreng A, Goldberg M (2002) Leukemia in relation to occupational exposures to benzene and other agents: a case-control study nested in a cohort of gas and electric utility workers. Am. J. Ind. Med. 42(2):87-97.
59. Hanzlik RP, Hogberg K, Dugson CM (1984) Microsomal hydroxylation of specifically deuterated monosubstituted benzenes. Evidence for direct aromatic hydroxylation. Biochemistry 23:3048-3055.
60. Hayes RB, Yin S-N, Dosemeci M, Li G-L,Wacholder S, Travis LB, Li C-Y, Rothman N, Hoover RN, Linet MS (1997) Benzene and the dose-related incidence of hematologic neoplasms in China. J. Natl. Cancer Inst. 89:1065-1071.
61. Hayes RB, Yin S, Rothman N, Dosemeci MM, Li G, Travis LT, Smith MT, Linet MS (2000) Benzene and lymphohematopoietic malignancies in China. J. Toxicol. Environ. Health 61:419-432.
62. Hayes RB, Songnian Y, Dosemeci M, Linet M (2001) Benzene and lymphohematopoietic malignancies in humans. Am. J. Ind. Med. 40:117-126.
63. HazelBA, Kalf GF (1996) Induction of granulocytic differentiation in myeloblasts by hydroquinone, a metabolite of benzene, involves the leukotriene D4 receptor. Receptors Signal Transduct. 6:1-12.
64. Hazel BA, O'Connor A, Niculescu R, Kalf GF (1996) Induction of granulocytic differentiation in a mouse model by benzene and hydroquinone. Environ. Health Perspect. 104:1257-1264.
65. Hedli CC, Rao NR, Reuhl KR, Witmer CM, Snyder R (1996) Effects of benzene metabolite treatment on granulocytic differentiation and DNA adduct formation in HL-60 cells. Arch. Toxicol. 70:135-144.
66. Hedli CC, Hoffmann MJ, Ji S, Thomas PE, Snyder R (1997) Benzene metabolism in the isolated perfused mouse liver. Toxicol. Appl. Pharmacol. 146:60-68.
67. Heijne WHM, Jonker D, Stierum RH, van Ommen B, Groten JP (2005) Toxicogenomic analysis of gene expression changes in rat liver after a 28-day oral benzene exposure. Mutat. Res./Fundam. Mol. Mech. Mutagen. 575:85-101.
68. Henderson AP, Barnes L, Bleasdale C (2005) Reactions of benzene oxide with thiols including glutathione. Chem. Res. Toxicol. 18:265-270.
69. Hirabayashi Y (2005) p53-dependent gene profiling for reactive oxygen species after benzene inhalation: special reference to genes associated with cell cycle regulation. Chem. Biol. Interact. 153-154:165-170.
70. HirakuY, Kawanishi S (1996) OxidativeDNAdamage and apoptosis induced by benzene metabolites. Cancer Res. 56:5172-5178.
71. Hornung RW, Ward E, Morris JA, Rinsky RA (1989) Letters to the editor. Toxicol. Ind. Health 5:1153-1155.
72. Huebner WW, Wojcik NC, Rosamilia K, Jorgensen G, Milano CA (2004) Mortality updates (1970-1997) of two refinery/petrochemical plant cohorts at Baton Rouge, Louisiana and Baytown. Texas J. Occup. Environ. Med. 46:1229-1245.
73. Huff J (1983) National Toxicology Program. Technical Report on the Toxicology and Carcinogenesis Studies of Benzene (CAS No. 71-43-2) in F344/N Rats and B6C3F1 Mice (Gavage Studies). Research Triangle Park, NC: National Institutes of Environmental Health Sciences.
74. Infante PF, Rinsky RA, Waggoner JK, Young RJ (1977) Leukemia in benzene workers. Lancet 2:76-78.
75. Irons RD (1985) Quinones as toxic metabolites of benzene. J. Toxicol. Environ. Health 16:673-678.
76. Irons RD, Stillman WS (1996) Impact of benzene metabolites on differentiation of bone marrow progenitor cells. Environ. Health Perspect. 104:1247-1250.
77. Irons RD, Dent JG, Baker TS, Rickert DE (1980) Benzene is metabolized and covalently bound in bone marrow in situ. Chem. Biol. Interact. 30:241-245.
78. Irons RD, Neptun DA, Pfeifer RW (1981) Inhibition of lymphocyte transformation and microtubule assembly by quinone metabolites of benzene: evidence for a common mechanism. J. Reticuloendothel. Soc. 30:359-371.
79. Irons RD, Greenlee WF, Wierda D, Bus JS (1982) Relationship between benzene metabolism and toxicity: a proposed mechanism for the formation of reactive intermediates from polyphenol metabolites. Adv. Exp. Med. Biol. 136:229-243.
80. Jaffe M (1909) Uber die Aufspaltung des Benzolring im Organismus. I. Mitteilung. Das Auftreten von Muconsaure im Harn nach Darreichung von Benzol. Hoppe-Seylers Z. Physiol. Chem. 62:58-67.
81. Jerina DM, Daly JW (1974) Arene oxides: a new aspect of drug metabolism. Science 185:573-582.
82. Johansson I, Ingelman-SundbergM (1983) Hydroxyl radical-mediated, cytochrome P450-dependent metabolic activation of benzene in microsomes and reconstituted enzyme systems from rabbit liver. J. Biol. Chem. 258:7311-7316.
83. Johansson I, Ingelman-Sundberg M (1988) Benzene metabolism by ethanol-, acetone-and benzeneinducible cytochrome P-450 (IIE1) on rat and rabbit liver microsomes. Cancer Res. 48:5387-5390.
84. Jowa L, Witz G, Snyder R, Winkle W, Kalf GF (1990) Synthesis and characterization of deoxyguanosine-benzoquinone adducts. J. Appl. Toxicol. 10:47-54.
85. Kalf GF, Schlosser MJ, Renz JF, Pirozzi ST (1989) Prevention of benzene-induced myelotoxicity by nonsteroidal anti-inflammatory drugs. Environ. Health Perspect. 82:57-64.
86. Kalf GF, Renz JF, Niculescu R (1996) p-Benzoquinone, a reactive metabolite of benzene, prevents the processing of pre-interleukins-1a and-1b to active cytokines by inhibition of the processing enzymes, calpain, and interleukin-1b converting enzyme. Environ. Health Perspect. 104:1251-1256.
87. Keller KA, Snyder CA (1986) Mice exposed in utero to low concentrations of benzene exhibit enduring changes in their colony forming hematopoietic cells. Toxicology 42:171-181.
88. Keller KA, Snyder CA (1988) Mice exposed in utero to 20 ppm benzene exhibit altered numbers of recognizable hematopoietic cells up to seven weeks after exposure. Fundam. Appl. Toxicol. 10:224-232.
89. Kipen HM, Cody RP, Crump KS, Allen B, Goldstein BD (1988) Hematologic effects of benzene: a thirty-five year longitudinal study of rubber workers. Toxicol. Ind. Health 4:411-430.
90. Kipen HM, Cody RP, Goldstein BD (1989a) Use of longitudinal analysis of peripheral blood counts to validate historical reconstruction of benzene exposure. Environ. Health Perspect. 82:199-206.
91. Kipen HM, Cody RP, Goldstein BD (1989b) Letters to the editor. Toxicol. Ind. Health 5:1156-1158.
92. Kirley TA, Goldstein BD, Maniara WM,Witz G (1989) Metabolism of trans,trans-muconaldehyde, a microsomal hematotoxic metabolite of benzene by purified yeast aldehyde dehydrogenase and a mouse liver soluble fraction. Toxicol. Appl. Pharmacol. 100:360-367.
93. Kline SA, Robertson JF, Grotz VL, Goldstein BD, Witz G (1993) Identification of 6-hydroxy-trans, trans-2,4-hexadienoic acid, a novel ring-opened urinary metabolite of benzene. Environ. Health Perspect. 101(4):310-312.
94. Kolachana P, Subrahmanyam VV, Meyer KB, Zhang L, Smith MT (1993) Benzene and its phenolic metabolites produce oxidativeDNAdamage in HL-60 cells in vitro and in the bone marrowin vivo. Cancer Res. 53:1023-1026.
95. Koop DR, Laethem CL, Schnier GG (1989) Identification of ethanol-inducible P450 isozyme 3a (P450IIE1) as a benzene and phenol hydroxylase. Toxicol. Appl. Pharmacol. 98:278-288.
96. Kreyon EM, Kraichely RE, Hudson KT, Medinsky MA (1996) Differences in rates of benzene metabolism correlate with observed genotoxicity. Toxicol. Appl. Pharmacol. 136:49-56.
97. Kukielka E, Cederbaum AI (1995) Increased oxidation of ethylene glycol to formaldehyde by microsomes after ethanol treatment: role of oxygen radicals and cytochrome P450. Toxicol. Lett. 78:9-15.
98. Lagorio S, Tagesson C, Forastiere F, Iavarone I, Axelson O, Carere A (1994) Exposure to benzene and urinary concentrations of 8-hydroxydeoxy-guanosine, a biological marker of oxidative damage to DNA. Occup. Environ. Med. 51:739-743.
99. Lan Q, Zhang L, Li G, Vermeulen R,Weinberg RS, Dosemeci M, Rappaport SM, Shen M, Alter BP, Wu Y, KoppW,Waidyanatha S, Rabkin C, GuoW, Chanock S, Hayes RB, Linet M, Kim S, Yin S, Rothman N, Smith MT (2004) Hematotoxicity in workers exposed to low levels of benzene. Science 306:1774-1776.
100. Lan Q, Zhang L, Shen M, SmithMT, Li G,Vermeulen R, Rappaport SM, Forrest MS, Hayes RB, Linet M, Dosemeci M, Alter BP, Weinberg RS, Yin S (2005) Polymorphisms in cytokine and cellular adhesion molecule genes and susceptibility to hematotoxicity among benzene-exposed workers. Cancer Res. 65:9574-9581.
101. Laskin DL, MacEachern L, Snyder R (1989) Activation of bone marrow phagocytes following benzene treatment of mice. Environ. Health Perspect. 82:75-79.
102. Laskin JD, Rao NR, Punjabi CJ, Laskin DL, Snyder R (1995) Distinct actions of benzene and its metabolites on nitric oxide production by bone marrow leukocytes. J. Leukocyte Biol. 57:422-426.
103. Laskin DL, Heck DE, Punjabi CJ, Laskin JD (2000) Nitric oxide as a mediator of benzene-induced hematosuppression and toxicity. J. Toxicol. Environ. Health A 61:413-417.
104. Latriano L, Zaccaria A, Goldstein BD,WitzG(1985) Muconaldehyde formation from 14C-benzene in a hydroxyl radical generating system. J. Free Radic. Med. Biol. 1:363-371.
105. Latriano L, Zaccaria A, Goldstein BD, Witz G (1986) Formation of muconaldehyde, an open-ring metabolite of benzene in mouse liver microsomes: a novel pathway for toxic metabolites. Proc. Natl. Acad. Sci. USA 83:8356-8360.
106. Lawyrk N, Weisel C (1996) Concentrations of volatile organic compounds in the passenger compartments of automobiles. Environ. Sci. Technol. 30:810-816.
107. Layton DM, Mufti GJ (1987) The myelodysplastic syndromes. Br. Med. J. 295:227-228.
108. Lee SS, Buters JT, Pineau T, Fernandez-Salquero P, Gonzalez FJ (1996) Role of CYP2E1 in the hepatotoxicity of acetaminophen. J. Biol. Chem. 15:3012-3022.
109. Lindsey RH, Bender RP, Osheroff N (2005) Stimulation of topoisomerase II-mediated DNA cleavage by benzene metabolites. Chem. Biol. Interact. 153-154:197-205.
110. Lindstrom AB, Yeowell-O'Connel K, Waidyanatha SB, Golding T, Tornero-Velez R, Rappaport SM (1997) Measurement of benzene oxide in blood of rats following administration of benzene. Carcinogenesis 18:1637-1641.
111. Lindstrom AB, Yeowell-O'Connel K, Waidyanatha S, McDonald TA, Golding BT, Rappaport SM (1998) Formation of hemoglobin and albumin adducts of benzene oxide in mouse, rat, and human blood. Chem. Res. Toxicol. 11:302-310.
112. Lindstrom AB, Yeowell-O'Connel K,Waidyanatha S, McDonald TA, Rappaport SM (1999) Investigation of benzene oxide in bone marrow and other tissues of F344 rats following metabolism of benzene in vitro and in vivo. Chem. Biol. Interact. 122:41-58.
113. Leo A, Hansch C, Elkins D (1971) Partition coefficients and their uses. Chem. Rev. 71:569.
114. LodenM(1986) The in vitro permeability of human skin to benzene, ethylene glycol, formaldehyde, and n-hexane. Acta Pharmacol. Toxicol. 58:382-389.
115. Loeff I, SteinG(1959) Aromatic ring opening in the presence of oxygen in irradiated solutions. Nature 184:901.
116. Long DJ II Gaikwad A, Multani A, Pathak S, Montgomery CA, Gonzalez FJ, Jaiswal A (2002) Disruption of the NAD(P)H:quinone oxidoreductase 1 (NQO1) gene in mice causes myelogenous hyperplasia. Cancer Res. 62:3030-3036.
117. Longacre LS, Kocsis JJ, Snyder R (1981) Influence of strain differences in mice on the metabolism and toxicity of benzene. Toxicol. Appl. Pharmacol. 60:398-409.
118. Lovern MR, Turner MJ, Meyer M, Kedderis GL, Bechtold WE, Schlosser PM (1997) Identification of benzene oxide as a product of benzene metabolism by mouse, rat, and human liver microsomes. Carcinogenesis 18:1695-1700.
119. Lovern MR, Cole CE, Schlosser PM (2001) A review of quantitative studies of benzene metabolism. Crit. Rev. Toxicol. 31:285-311.
120. Lunte SM, Kissinger PT (1983) Detection and identification of sulfhydryl conjugates of p-benzoquinone in microsomal incubations of benzene and phenol. Chem. Biol. Interact. 47:195-212.
121. Maltoni C, Conti B, Cotti G (1983) Benzene: a multipotential carcinogen. Results of long-term bioassays performed at the Bologna Institute of Oncology. Am. J. Ind. Med. 4:589-630.
122. McDonald TA, Yeowell-O'Connel K, Rappaport SM (1994) Comparison of protein adducts of benzene oxide and benzoquinone in the blood and bone marrow of rats and mice exposed to [14C=13C6] benzene. Cancer Res. 54:4907-4914.
123. Medeiros AM, Bird MG, Witz G (1997) Potential biomarkers of benzene exposure. J. Toxicol. Environ. Health 51:519-539.
124. Moran JL, SiegelD, Sun X-M, RossD(1996) Induction of apoptosis by benzene metabolites in HL-60 and CD34{thorn} human bone marrow progenitor cells. Mol. Pharmacol. 50:610-615.
125. National Academy of Sciences (NAS) (1989) Biomarkers in Reproductive Toxicology. Washington, DC: National Academy Press.
126. Nencki M, Giacosa P (1880) Uber die oxydation der aromatischen wasserstoffe in Turkoyser. Z. Physiol. Chem. 4:325.
127. Norpoth K, Stucker W, Krewet E, Muller G (1988) Biomonitoring of benzene exposure by trace analysis of phenylguanine. Int. Arch. Occup. Environ. Health 60:163-168.
128. Nwosu VC, Kissling GE, Trempus CS, Honeycutt H, French JE (2004) Exposure of Tg.AC transgenic mice to benzene suppresses hematopoietic progenitor cells and alters gene expression in critical signaling pathways. Toxicol. Appl. Pharmacol. 196:37-46.
129. Ong CN, Kok PW, Lee BL, Shi CY, Ong HY, Chia KS, Lee CS, Luo XW (1995) Evaluation of biomarkers for occupational exposure to benzene. Occup. Environ. Med. 52:528-533.
130. Parke DV, Williams RT (1953) Studies in detoxification. 44. The metabolism of benzene containing 14C-benzene. Biochem. J. 54:231-238.
131. Paxton MB, Chinchilli VM, Brett SM, Rodricks JV (1994) Leukemia risk associated with benzene exposure in the Pliofilm cohort. I. Mortality update and exposure distribution. Risk Anal. 14:147-154.
132. Paxton MB, Chinchilli VM, Brett SM, Rodricks JV (1994) Leukemia risk associated with benzene exposure in the Pliofilm cohort. II. Risk estimates. Risk Anal. 14:155-161.
133. Pellack-Walker P, Blumer JL (1986) DNA damage in L5178YS cells following exposure to benzene metabolites. Mol. Pharmacol. 30:42-47.
134. Porteous JW, Williams RT (1953) Studies in detoxication. 49. The metabolism of phenol, catechol, quinol and hydroxyquinol from the ethereal sulfate fraction of the urine of rabbits receiving benzene orally. Biochem. J. 44:56-61.
135. Powley MW, Carlson GP (1999) Species comparison of hepatic and pulmonary metabolism of benzene. Toxicology 139:207-217.
136. PowleyMWand Carlson GP (2000) Cytochromes P450 involved with benzene metabolism in hepatic and pulmonary microsomes. J. Biochem. Mol. Toxicol. 14(6):303-309.
137. Qu Q, Shore R, Li G, Jin X, Chen LC, Cohen B, Melikian AA, Eastmond D, Rappaport S, Li H, Rupa D, Waidyanatha S, Yin S, Yan H, Meng M, Winnik W, Kwok ES, Li Y, Mu R, Xu B, Zhang X, Li K (2003) Validation and Evaluation of Biomarkers in Workers Exposed to Benzene in China. HEI Research Report 115.
138. Qu Q, Shore R, Li G, Su L,YinX, Melikian AA, Roy N, Chen LC,Wirgin E, Cohen B,Yin S, LiY,Mu R (2005) Biomarkers of benzene exposure: urinary metabolites in relation to individual genotype and personal exposure. Chem. Biol. Interact. 153-154:85-95.
139. Quitt M, Cassel A, Yoffe A, Anatol AM, Froom P (2004) Autonomous growth of committed hematopoietic progenitors from peripheral blood of workers exposed to low levels of benzene. J. Occup. Environ. Med. 46:27-29.
140. Rana SV, Verma Y (2005) Biochemical toxicity of benzene. J. Environ. Biol. 26:157-168.
141. Rao GS (1996) Glutathionyl hydroquinone: a potent prooxidant and a possible toxic metabolite of benzene. Toxicology 106:49-54.
142. Rappaport SM,Waidyanatha S, Qu Q, Shore R, Jin X, Cohen B, Chen LC, Melikian AA, Li G, Yin S, Yan H, Xu B, Mu R, Li Y, Zhang X, Li K (2002) Albumin adducts of benzene oxide and 1,4-benzoquinone as measures of human benzene metabolism. Cancer Res. 62:1330-1337.
143. Rappaport SM,Waidyanatha S, Yeowell-O'Connel K, Rothman N, Smith MT, Zhang L, Qu Q, Shore R, Li G, Yin S (2005) Protein adducts as biomarkers of human benzene metabolism. Chem. Biol. Interact. 153-154:103-109.
144. Rickert DE, Baker TS, Bus JS, Barrow CS, Irons RD (1979) Benzene disposition in the rat after exposure by inhalation. Toxicol. Appl. Pharmacol. 49:417-423.
145. Rinsky RA, Young RJ, Smith AB (1981) Leukemia in benzene workers. Am. J. Ind. Med. 2:217-245.
146. Rinsky RA, Smith AB, Hornung R, Filloon TG, Young RF, Okun AD, Landrigan PJ (1987) Benzene and leukemia: an epidemiological risk assessment. N. Engl. J. Med. 316:1044-1050.
147. Rivedal E,Witz G (2005) Benzene metabolites block gap junction intracellular communication. Role in hematotoxicity and leukemia? Chem. Biol. Interact. 153-154:257-260.
148. Rosenthal GJ, Snyder CA (1985) Modulation of the immune response to Listeria monocytogenes by benzene inhalation. Toxicol. Appl. Pharmacol. 80:502-510.
149. Rosenthal GJ, SnyderCA(1987) Inhaled benzene reduces aspects of cell-mediated tumor surveillance in mice. Toxicol. Appl. Pharmacol. 88:35-43.
150. Ross D (2000) The role of metabolism and specific metabolites in benzene-induced toxicity: evidence and issues. J. Toxicol. Environ. Health A 61:357-372.
151. Ross D (2005) Functions and distribution of NQO1 in human bone marrow: potential clues to benzene toxicity. Chem. Biol. Interact. 153-154:137-146.
152. Rothman N, Smith MT, Hayes RB , et al. (1997) Benzene poisoning, a risk factor for hematological malignancy, is associated with the NQO1 609C × T mutation and rapid fractional excretion of chlorzoxazone. Cancer Res. 57:2839-2842.
153. Rothman N, Haas R, Hayes RB, Li G-L,Wiemels J, Campleman S, Quintana PJE, Xi LJ, Dosemeci M, Titenko-Holland N, Meyer KB, LuW, Zhang LP, BechtoldW,Wang YZ,Kolachana P,Yin SN, Blot W, Smith MT (1995) Benzene induces gene-duplicating but not gene-inactivating mutations at the glycophorin A locus in exposed humans. Proc. Natl. Acad. Sci. USA 92:4069-4073.
154. Rothman N, Li G-L, Dosemeci M, BechtoldW, Marti GE,Wang Y-Z, Linet M, Xi L-Q, LuW, Smith MT, Titenko-Holland N, Zhang L-P, Blot W, Yin S-N, Hayes RB (1996) Hematotoxicity among Chinese workers heavily exposed to benzene. Am. J. Ind. Med. 29:236-246.
155. Rozen MG and Snyder CA (1985) Protracted exposure of C57BL/6 mice 300 ppm benzene depresses B-and T-lymphocyte numbers and mitogen responses. Evidence for thymic and bone marrow proliferation in response to the exposures. Toxicology 37(1-2):13-26.
156. Sabourin PJ, Chen BT, Lucier G, Birnbaum LS, Fisher E, Henderson RF (1987) Effect of dose on the absorption and excretion of [14C] benzene administered orally or by inhalation in rats and mice. Toxicol. Appl. Pharmacol. 87:325-336.
157. Sabourin PJ, Bechtold WE, Birnbaum LS, Lucier G, Henderson RF (1988a) Differences in the metabolism and disposition of inhaled [3H] benzene by F344/N rats and B6C3F1 mice. Toxicol. Appl. Pharmacol. 94:128-140.
158. Sabourin PJ, Bechtold WE, Henderson RF (1988b) A high pressure liquid chromatographic method for the separation and quantitation of water-soluble radiolabeled benzene metabolites. Anal. Biochem. 170:316-327.
159. Sabourin PJ, Bechtold WE, Griffith WC, Birnbaum LS, Lucier G, Henderson RF (1989) Effect of exposure concentration, exposure rate, and route of administration on metabolism of benzene by F344 rats and B6C3F1 mice. Toxicol. Appl. Pharmacol. 99:421-444.
160. Sabourin PJ, Sun JD, MacGregor JT,Wehr CM, Birnbaum CG, Lucier G, Henderson RF (1990) Effect of repeated benzene inhalation exposures on benzene metabolism, binding to hemoglobin, and induction of micronuclei. Toxicol. Appl. Pharmacol. 103:452-462.
161. Sadler A, Subrahmanyam VV, Ross D (1988) Oxidation of catechol by horseradish peroxidase and human leukocyte peroxidase: reactions of o-benzoquinone and o-benzosemiquinone. Toxicol. Appl. Pharmacol. 93:62-71.
162. Sammett D, Lee EW, Kocsis JJ, Sunder R (1979) Partial hepatectomy reduces both metabolism and toxicity of benzene. J. Toxicol. Environ. Health 5:785-792.
163. Sato A, Nakajima T (1979) Partition coefficients of some aromatic hydrocarbons and ketones in water, blood and oil. Toxicol. Appl. Pharmacol. 48:49.
164. Savitz D, Andrews KW (1997) Review of epidemiologic evidence on benzene and lymphatic and hematopoietic cancers. Am. J. Ind. Med. 31:287-295.
165. Sawahata T, Neal RA (1982) Horseradish peroxidase-mediated oxidation of phenol. Biochem. Biophys. Res. Commun. 109:988-994.
166. Sawahata T, Rickert DA, Greenlee WF (1985) Metabolism of benzene and its metabolites in bone marrow. In: Irons R, editor. Toxicology of the Blood and Bone Marrow.NewYork:Raven Press, pp. 141-148.
167. Schnatter AR, Nicolich MJ, Bird MG (1996) Determination of leukemogenic benzene exposure concentrations: refined analyses for the Pliofilm cohort. Risk Anal. 16:833-840.
168. Schnatter AR, Rosamilia K, Wojcik NC (2005) Review of the literature on benzene exposure and leukemia subtypes. Chem. Biol. Interact. 153-154:9-21.
169. Schoenfeld H,Witz G (2000) Structure-activity relationships in the induction of DNA-protein crosslinks by hematotoxic ring-opened benzene metabolites and related compounds in HL60 cells. Toxicol. Lett. 116:79-88.
170. Schoenfeld HA, Radbourne R, Goldstein BD,Witz G (1996) Mechanistic studies on benzene toxicity: formation of DNA-protein crosslinks induced by benzene in mice and muconaldehyde in HL-60 cells. Fundam. Appl. Toxicol. (Suppl.) 30:232.
171. Schoenfeld HA, Mirochnitchenko O, Goldstein BD, Witz G (1997) Effects of trans,trans-muconaldehyde, a hematotoxic benzene metabolite, orDNA-protein crosslink levels and on apoptosis in mouse bone marrow cells. Fundam. Appl. Toxicol. (Suppl.) 31:163.
172. Schrenk DM, Ingelman-Sundberg, Bock KW (1992) Influence of P-4502E1 induction on benzene metabolism in rat hepatocytes and on biliary metabolite excretion. Drug Metab. Dispos. 20: 137-141.
173. Schultzen O, Naunyn B (1867) Uber das Verhalten des Kohlenwasserstoffes im Organisms. Arch. Anat. Physiol. 1:349.
174. Schwartz CS, Snyder R,KalfGF (1985) The inhibition of mitochondrialDNAreplication in vitro by the metabolites of benzene hydroquinone and p-benzoquinone. Chem. Biol. Interact. 53:327-350.
175. Seaton MJ, Schlosser PM, Bond JA, Medinsky MA (1994) Benzene metabolism by human liver microsomes in relation to cytochrome P450 2E1 activity. Carcinogenesis 15:1799-1806.
176. Sheets P, Carlson G (2004) Kinetic factors involved in the metabolism of benzene in mouse lung and liver. J. Toxicol. Environ. Health A 67:421-430.
177. Shen M, Lan Q, Zhang L, Chanock S, Li G, Vermeulen R, Rappaport SM, GuoW, Hayes RB, Linet M, eager M,Welch R, Forrest MS, Rothman N, SmithMT(2006) Polymorphisms in genes involved in DNA double-strand break repair pathway and susceptibility to benzene-induced hematotoxicity. Carcinogenesis 27:2083-2089.
178. Sherwood RJ, Sinclair GC (1999) New PBPK model applied to old occupational exposure to benzene. Am. Ind. Hyg. Assoc. J. 60:259-265.
179. Smart RC, Zannoni VG (1985) DT-diaphorase and peroxidase influence the covalent binding of metabolites of phenol, the major metabolite of benzene. Mol. Pharmacol. 26:105-111.
180. SmithMT(1996) The mechanism of benzene-induced leukemia: a hypothesis and speculations on the causes of leukemia. Environ. Health Perspect. 104:1219-1225.
181. Smith MT, Yager JW, Steinmetz KL, Eastmond DA (1989) Peroxidase-dependent metabolism of benzene's phenolic metabolites and its potential role in benzene toxicity and carcinogenicity. Environ. Health Perspect. 82:23-29.
182. SmithMT,Vermeulen R, Li G, Zhang L, Lan Q, Hubbard AE, Forrest MS, McHale C, Zhao X, Gunn L, Shen M, Rappaport SM,Yin S, Channock S, RothmanN(2005) Use of 'omic' technologies to study humans exposed to benzene. Chem. Biol. Interact. 153-154:123-127.
183. Snyder CA (1987) Benzene. In: Snyder R, editor. Ethel Browning's Toxicity and Metabolism of Industrial Solvents, Vol. I. Hydrocarbons, 2nd edn.Amsterdam:Elsevier, pp. 3-27.
184. Snyder R (2002) Benzene and leukaemia. Crit. Rev. Toxicol. 32:155-210.
185. Snyder R (2004) Xenobiotic metabolism and the mechanism(s) of benzene toxicity. Drug Metab. Rev. 36:531-547.
186. Snyder CA, Goldstein BD, Sellakumar A (1978) Hematotoxicity of inhaled benzene to Sprague-Dawley rats and AKR mice at 300 ppm. J. Toxicol. Environ. Health 4:605-618.
187. Snyder CA, Goldstein BD, Sellakumar AR, Bromberg I, Laskin S, Alberts RE (1980) The inhalation toxicology of benzene: incidence of hematopoietic neoplasms and hematotoxicity in ARK/J and C57BL/6J mice. Toxicol. Appl. Pharmacol. 54:323-331.
188. Snyder R, Witz G, Goldstein BD (1993) The toxicology of benzene. Environ. Health Perspect. 100:293-306.
189. Sorahan T, Kinlen LJ, Doll R (2005) Cancer risks in a historical UK cohort of benzene exposed workers. Occup. Environ. Med. 62:231-236.
190. Steffen C, Auclerc MF, Auvrignon A, Baruchel A, Kebaili K, Lambilliotte A, Leverger G, Sommelet D, Vilmer E, Hemon D, Clavel J (2004) Acute childhood leukemia and environmental exposure to potential sources of benzene and other hydrocarbons: a case-control study. Occup. Environ. Med. 61:773-778.
191. Subrahmanyam VV, O'Brien PJ (1985) Phenol oxidation product(s) formed by a peroxidase reaction that bind to DNA. Xenobiotica 15:873-885.
192. Subrahmanyam VV, Ross D, Eastmond DA, Smith MT (1991) Potential role of free radicals in benzene-induced myelotoxicity and leukaemia. Free Radic. Biol. Med. 11:495-515.
193. Tavassoli M, Friedenstein A (1983) Hemapoietic stromal microenvironment. Am. J. Hematol. 14:195-203.
194. Thibodeaux LJ (1981) Estimating the air emissions of chemicals from hazardous waste landfills. J. Hazard. Mater. 4:235-244.
195. Tunek A, Platt KL, Przybylski M, Oesch F (1980) Multistep metabolic activation of benzene. Effect of superoxide dismutase on covalent binding to microsomal macromolecules and identification of glutathione conjugates using high pressure liquid chromatography and field desorption mass spectrometry. Chem. Biol. Interact. 33:1.
196. Valentine JL, Lee SS-T, Seaton MJ, Asgharian B, Farris G, Corton JC, Gonzalez FJ, Medinsky MA (1996) Reduction of benzene metabolism and toxicity in mice that lack CYP2E1 expression. Toxicol. Appl. Pharmacol. 141:205-213.
197. VanWendel de Joode B, Tielemans E, Vermeulen R,Wegh H, Kromhout H (2005) Dermal exposure assessment to benzene and toluene using charcoal cloth pads. J. Expo. Anal. Environ. Epidemiol. 15:47-50.
198. Vermeulen R, Li G, an Q, Dosemeci M, Rappaport SM, Bohong X, Smith MT, Zhang L, Hayes RB, Linet M, Mu R, Wang L, Yu J, Yin S, Rothman N (2004) Detailed exposure assessment for a molecular epidemiology study of benzene in two shoe factories in China. Ann. Occup. Hyg. 48:105-116.
199. Waidyanatha S, Rothman N, Li G, SmithMT, Yin S, Rappaport SM (2004) Rapid determination of six urinary benzene metabolites in occupationally exposed and unexposed subjects. Anal. Biochem. 327:184-199.
200. Wallace LA (1987) The Total Exposure Assessment Methodology (TEAM) Study: Summary and Analysis, Vol. I. EPA-600-6-87-002a. Washington, DC: U.S. EPA, Office of Acid Deposition, Environmental Monitoring and Quality Assurance.
201. Wallace LA, Pellizzari ED (1986) Personal air exposures and breath concentrations of benzene and other volatile hydrocarbons for smokers and nonsmokers. Toxicol. Lett. 35:113-116.
202. Wallace LA, Sparacino C, Sheldon LS, Zelon H (1985) Personal exposures, indoor-outdoor relationships, and breath levels of toxic air pollutants measured for 355 persons in New Jersey. Atmos. Environ. 19:1651-1661.
203. Wallace LA, Pellizzari ED, Harwell TD, Waidyanatha S, Rothman N, Li G, Smith MT, Yin S, Rappaport SM (2004) Rapid determination of six urinary benzene metabolites in occupationally exposed and unexposed subjects. Anal. Biochem. 327:184-199.
204. Walling C, Johnson RA (1975) Fenton's reagent. V. Hydroxylation and side chain cleavage of aromatics. J. Am. Chem. Soc. 97:363-367.
205. Wan J, Badham HJ, Winn L (2005) The role of c-MYB in benzene-initiated toxicity. Chem. Biol. Interact. 153-154:171-178.
206. Ward E, Hornung R, Morris J, Rinsky R, Wild D, Halperin W, Guthrie W (1996) Risk of low red or white blood cell count related to estimated benzene exposure in a rubberworker cohort (1940-1975). Am. J. Ind. Med. 29:247-257.
207. Weisel C, Yu R, Roy A, Georgopoulos P (1996) Biomarkers of environmental benzene exposure. Environ. Health Perspect. 104: (Suppl. 5)1141-1146.
208. Whysner J, Reddy MV, Ross PM, Mohan M, Lax EA (2004) Genotoxicity of benzene and its metabolites. Mutat. Res. 566:99-130.
209. Wiedra D, Irons RD, Greenlee WF (1981) Immunotoxicity in C57BL/6 mice exposed to benzene and Aroclor 1254. Toxicol. Appl. Pharmacol. 60:410-417.
210. Williams PR, Paustenbach DJ (2003) Reconstruction of benzene exposure for the Pliofilm cohort (1936-1976) using Monte Carlo techniques. J. Toxicol. Environ. Health 66:677-781.
211. Witz G, Rao GS, Goldstein BD (1985) Short term toxicity of trans,trans-muconaldehyde. Toxicol. Appl. Pharmacol. 80:511-516.
212. Witz G, ManiaraWM,Mylavarapu VJ, GoldsteinBD(1990) Comparative metabolism of benzene and trans,trans-muconaldehyde to trans,trans-muconic acid in DBA/2N and C57BL/6 mice. Biochem. Pharmacol. 40:1275-1280.
213. Witz G, Zhang Z, Goldstein BD (1996) Reactive ring-opened aldehyde metabolites in benzene hematotoxicity. Environ. Health Perspect. 104:1195-1199.
214. Wong O (2002) Investigations of benzene exposure, benzene poisoning and malignancies in China. Regul. Toxicol. Pharmacol. 35:126-135.
215. Wong O, Raabe GK (2000) Non-Hodgkin's lymphoma and exposure to benzene in a multinational cohort of more than 308,000 petroleum workers, 1937 to 1996. J. Occup. Environ. Med. 42: 554-568.
216. World Health Organization (WHO) (1987) Air Quality Guideline for Europe.Copenhagen:WHO Regional Publications.
217. Wu D, Cederbaum AI (1994) Characterization of pyrazole and 4-methylpyrazole induction of cytochrome P4502E1 in rat kidney. J. Pharm. Exp. Ther. 270:407-413.
218. Yamanaka K, Hayashi H, Kato K, Hasegawa A, Okada S (1995) Involvement of preferential formation of apurinic/apyrimidinic sites in dimethylarsenic-induced DNA strand breaks and DNA-protein crosslinks in cultured alveolar epithelial cells. Biochem. Biophys. Res. Commun. 207:244-249.
219. Yardley-Jones A, Anderson D, Jenkinson PC, Lovell DP, Blowers SD, Davies MJ (1988) Genotoxic effects in peripheral blood and urine of workers exposed to low level benzene. Br. J. Ind. Med. 45:694-700.
220. Yeowell O'Connell K, Rothman N, Waidyanatha S, Smith MT, Hayes RB, Li G, Bechtold WE, Dosemeci M, Zhang L, Yin S, Rappaport SM (2001) Protein adducts of 1,4-benzoquinone and benzene oxide among smokers and nonsmokers exposed to benzene in China. Cancer Epidemiol. Biomarkers Prev. 10:831-838.
221. Yin SN, Li G-L, Tain F-D, Fu Z-I, Jin C, ChenY-J, Luo S-J,Ye P-Z, Zhang J-Z,Wang G-C, Zhang X-C, Wu H-N, Zhong Q-C (1987a) Leukemia in benzene workers: a retrospective cohort study. Br. J. Ind. Med. 44:124-128.
222. Yin S-N, Hayes RB, Linet MS, Li G-L, Dosemeci M, Travis LB, Li C-Y, Zhang Z-N, Li D-G, Chow W-H,Wacholder S,WangY-Z, Jiang Z-L, Dai T-R, ZhangW-Y, Chao X-J,Ye P-Z,Kou Q-R, Zhang X-C, Lin X-F, Meng J-F, Ding C-Y, Zho J-S, Blot WJ (1996) A cohort study of cancer among benzene-exposed workers in China: overall results. Am. J. Ind. Med. 29:227-235.
223. Yin SN, Hayes RB, Linet MS, Li GL, Dosemeci M, Travis LB, Zhang ZN, Li DG, Chow WH, Wacholder S, Blot WJ (1996b) An expanded cohort study of cancer among benzene-exposed workers in China. Benzene Study Group. Environ Health. Perspect. 104S6:1336-1341.
224. Yoon B, Li G, Kitada K, Kawasaki Y, Igarashi K, Kodama Y, Inoue T, Kobayashi K, Kanno J, Kim D, Inoue T, Hirabayashi Y (2003) Mechanisms of benzene-induced hematoxicity and leukemogenicity: cDNA microarray analyses using moue bone marrow tissue. Environ. Health Perspect. 111:1411-1420.
225. Young N (1989) Benzene and lymphoma. Am. J. Ind. Med. 15:495-498.
226. Yu R, Weisel C (1996) Measurement of benzene in human breath associated with an environmental exposure. J. Expo. Anal. Environ. Epidemiol. 6:261-277.
227. Zeise L, McDonald TA(2000) California perspective on the assessment of benzene toxicological risks. J. Toxicol. Environ. Health A 61:479-483.
228. Zhang Z, Kline SA, Kirley TA, Goldstein BD,WitzG(1993) Pathways of trans,trans-muconaldehyde metabolism in mouse liver cytosol: reversibility of monoreductive metabolism and formation of end products. Arch. Toxicol. 67:461-467.
229. Zhang Z, Xiang Q, Glatt H, Platt KI, Goldstein BD, Witz G (1995a) Studies on pathways of ring opening of benzene in a Fenton system. Free Radic. Biol. Med. 18:411-419.
230. Zhang Z, Goldstein BD, Witz G (1995b) Iron-stimulated ring-opening of benzene in a mouse liver microsomal system. Mechanistic studies and formation of a newmetabolite. Biochem. Pharmacol. 50:1607-1617.
231. Zhang Z, Schafer F, Schoenfeld H, Cooper K, Snyder R, Goldstein BD, Witz G (1995c) The hematotoxic effects of 6-hydroxy-trans,trans-2,4-hexadienal, a reactive metabolite of trans, trans-muconaldehyde, in CD-1 mice. Toxicol. Appl. Pharmacol. 132:213-219.
232. Zhang L, Eastmond DA, Smyth MT (2002) The nature of chromosomal aberrations detected in humans exposed to benzene. Crit. Rev. Toxicol. 32:1-42.